CR Sanjiu(SZ:000999) Shang Hai Zheng Quan Bao·2025-12-30 23:29Core Viewpoint - The announcement details the renewal of an energy supply agreement between China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. and its subsidiary, Chenzhou Sanjiu Pharmaceutical Co., Ltd., with Chenzhou China Resources Gas Co., Ltd. for the supply of cooling, heating, and steam energy from January 1, 2026, to December 31, 2028, with a total transaction amount not exceeding RMB 99 million [2][3][18]. Group 1: Overview of Related Transactions - The agreement aims to meet the energy needs of Chenzhou Sanjiu's production center in South China, ensuring continuous business operations [2][18]. - The total expected transaction amounts for the years 2026, 2027, and 2028 are RMB 30 million, RMB 33 million, and RMB 36 million, respectively [2][8]. - The agreement is classified as a related party transaction due to both parties being controlled by the same entity, China Resources Limited [3][6]. Group 2: Financial and Operational Details - Chenzhou China Resources Gas Co., Ltd. reported revenues of RMB 365 million and a net profit of RMB 4.63 million for 2024, with a net asset value of RMB 244.13 million as of December 31, 2024 [7]. - The pricing for energy supply is based on market fair prices, with specific discounts applied to electricity rates and capped prices for steam, cooling, and heating [8][10][11]. Group 3: Agreement Terms and Conditions - The agreement includes provisions for energy supply, pricing, payment methods, and responsibilities of both parties, ensuring compliance with relevant laws and regulations [9][12][13]. - The agreement will automatically expire if not extended before its expiration date, and any assets created during the project will belong to the energy supplier [17]